Ceramides are natural skin fats. Creams have the strongest evidence for helping skin hold moisture and repair its barrier; oral plant ceramides give smaller, slower hydration gains, most noticeable in already-dry skin. Benefits are modest but real. Certain blood ceramides are a warning sign for metabolic and heart disease, not a proven harm of supplements, which appear well tolerated. (Full Review)

Protocol

Oral Dose

30–70 mg/day

Wheat glucosylceramide; or 600–1,200 µg rice/konjac

Topical

Twice daily

Onto clean, slightly damp skin

Dosing

Once daily

Any consistent time, with a meal

Time to effect

Topical barrier repair

2–4 weeks

Hydration rises, moisture loss falls

Oral hydration

8–12 weeks

Improved skin hydration vs placebo

Oral barrier

12 weeks

Reduced transepidermal water loss

Benefits

High: Topical barrier repair and hydration

Medium: Oral supplementation improves skin hydration; reduced transepidermal water loss

Low: Improved visible signs of skin ageing; relief of dry, itch-prone skin

Speculative: Support for skin immune and barrier–microbiome balance

Contraindications

Confirmed wheat allergy or celiac disease (wheat-derived products)

Known allergy to the specific plant source

Key Interactions

Pregnancy, breastfeeding, children (precautionary, insufficient data)

Risk & Side Effects

High: Allergic reactions in wheat-, rice-, or plant-sensitive people

Medium: Mild gastrointestinal discomfort; sparse long-term safety data

Low: Topical formulation irritation or breakouts

Speculative: Theoretical contribution to circulating ceramide load

Monitoring

Marker	Target	Why
Skin hydration (corneometry)	Higher than baseline	Tracks stratum corneum water content and barrier improvement
Transepidermal water loss	<10–15 g/m²/h (forearm)	Indicates barrier integrity; falls as the barrier repairs
Plasma ceramide risk score	Low-risk category	Flags cardiometabolic risk tied to specific ceramide species
Fasting glucose / HbA1c	70–85 mg/dL; <5.4%	Screens the insulin resistance that raises harmful ceramides
Fasting insulin	<6 µIU/mL	Early marker of insulin resistance before glucose rises
Apolipoprotein B	<80 mg/dL	Counts artery-clogging particles; complements ceramide-based risk

Cadence: Skin measures at 4, 8, 12 weeks, then every 3–6 months; metabolic labs every 6–12 months

Qualitative Assessment

Softer, smoother-feeling skin and less visible flaking
Reduced sensation of tightness or dryness, especially in winter or dry climates
Less itch in previously dry areas
Improved skin comfort and radiance by self-assessment and photo comparison

Ceramides for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment